Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-97.06	-1.32	44.85
Graham Fair Price	inf	0.00	2.01
PEG	0.00	0.00	0.00
Price/Book	inf	0.00	5.32
Price/Cash Flow	inf	0.00	-29.83
Prices/Earnings	inf	0.00	155.06
Price/Sales	inf	0.00	5.70
Price/FCF	inf	0.00	-29.83
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	3.82	0.50	0.48
Operating Margin	-62.84	0.04	0.10
ROA	-37.04	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-38.23
ROIC	0.01	< 0.005	-40.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-1.00	0.00	-100.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	-0.66	-100.00
EPS QOQ	0.00	-1.00	-100.00
FCF QOQ	0.00	1.00	100.00
Revenue QOQ	0.00	-0.08	-100.00
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	195.10	225.59	15.63
Days Sales Outstanding (DSO)	360.18	78.16	-78.30
Inventory Turnover	0.46	0.40	-13.52
Debt/Capitalization	0.51	0.27	-46.78
Quick Ratio	0.63	0.54	-15.34
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	4.59	0.00	inf
Cash	0.64	0.00	inf
Capex	-0.27	0.00	inf
Free Cash Flow	-0.82	0.00	inf
Revenue	4.28	0.00	inf
Naive Interpretation	member

05 - Per Share Metrics · Not Interpreted

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.32	1.26	-4.21
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.94	-1.32	-80.99
Naive Interpretation	Member

06 - Financial Health · Weak

Rating